| 90145 |
10(E),12(Z)-Conjugated Linoleic Acid
|
|
2420-56-6 |
≥98%
|
|
|
|
18.494640883978
|
10-e-12-z-conjugated-linoleic-acid
|
10E,12Z-CLA
|
PPAR.gamma. .DELTA.6-desaturase antioxidants antitumor 10E,12Z- octadecadienoic PPARgamma DELTA6- d6- conjugated fatty acids peroxisome proliferator-activated receptors |
18.494640883978
|
| 10976 |
10-HDA
|
|
14113-05-4 |
≥98%
|
|
|
2011-10-13
|
79.840110497237
|
10-hda
|
|
fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen |
79.840110497237
|
| 10008043 |
10-Nitrooleate
|
|
88127-53-1 |
≥98%
|
|
|
2006-08-01
|
33.116261510129
|
10-nitrooleate
|
10-nitro-9-trans-Octadecenoic Acid
|
oleic acids nitration 9-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes |
33.116261510129
|
| 10008128 |
10(S),17(S)-DiHDoHE
Exclusive
|
|
871826-47-0 |
≥98%
|
|
✓ |
2007-08-21
|
106.761685082873
|
10-s-17-s-dihdohe
|
PDX; Protectin DX
|
inflammation resolution resolvins neuroprotection neurodegeneration Alzheimer's disease NPD1 PD1 RvE1 dihydroxy DHA 10S,17S dihydroxy DHA anti-inflammatory neuroprotectin d1 protectin d1 10(s), 17(s)-dihdohe protectin-dx protectindx |
106.761685082873
|
| 10462 |
11(12)-EpETE
Exclusive
|
|
504435-15-8 |
≥98%
|
|
✓ |
2010-10-28
|
6.426522176380
|
11-12-epete
|
11,12-EEQ; 11,12-Epoxyeicosatetraenoic Acid
|
eicosapentaenoic acids EPAs epoxyeicosatetraenoic EpETE EETeTr cytochromes P450 epoxygenases CYP450 10-[3-2Z,5Z-octadien-1-yl-2-oxiranyl]-5Z,8Z-decadienoic acid 11,12-epoxyeicosatrienoic acid |
6.426522176380
|
| 90192 |
11(Z),14(Z),17(Z)-Eicosatrienoic Acid
|
|
17046-59-2 |
≥98%
|
|
|
|
1.832154696132
|
11-z-14-z-17-z-eicosatrienoic-acid
|
|
polyunsaturated essential fatty acids 11Z,14Z,17Z-eicosatrienoic PUFA w-3 omega-3 .omega.-3 |
1.832154696132
|
| 90330 |
11(Z),14(Z)-Eicosadienoic Acid
|
|
2091-39-6 |
≥98%
|
|
|
|
6.291104972375
|
11-z-14-z-eicosadienoic-acid
|
|
polyunsaturated fatty acids PUFAs |
6.291104972375
|
| 10009832 |
(±)12,13-DiHOME
|
|
263399-35-5 |
≥98%
|
|
|
2007-06-26
|
4.069465930018
|
-12-13-dihome
|
Isoleukotoxin diol
|
epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 |
4.069465930018
|
| 10009994 |
(±)12,13-DiHOME-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
2007-06-26
|
4.188692449355
|
-12-13-dihome-d4
|
Isoleukotoxin diol-d4
|
epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 mass spectrometry MS deuterated deuterium |
4.188692449355
|
| 10009879 |
1,2-Didecanoyl PC
|
|
3436-44-0 |
≥98%
|
|
|
2007-08-02
|
3.969530386740
|
1-2-didecanoyl-pc
|
1,2-Didecanoyl Phosphatidylcholine; Didecanoyl Lecithin
|
lecithin phosphatidylcholines phospholipids mammalian cells membranes lipids growth hormones GH intranasally |
3.969530386740
|
| 10009873 |
1,2-Dioleoyl PC
|
|
56648-95-4 |
≥98%
|
|
|
2008-08-20
|
3.969392265193
|
1-2-dioleoyl-pc
|
1,2-Dioleoyl-sn-glycero-3-Phosphatidylcholine; DOPC
|
DOPC Phospholipid bilaye Fatty acid siRNA liposome |
3.969392265193
|
| 10138 |
(±)12-HpETE
|
|
71030-35-8 |
≥96%
|
|
|
|
31.989513812154
|
-12-hpete
|
|
(±)12-HpETEs hydroperoxides (±)12HpETEs hydroperoxy arachidonic fatty acids racemic hydroxy fatty acids autoxidation (±)-HpETEs (±)HpETEs |
31.989513812154
|
| 10008875 |
13(S)-HODE methyl ester
|
|
109837-85-6 |
≥98%
|
|
|
2006-12-05
|
16.549911602209
|
13-s-hode-methyl-ester
|
|
hydroxy fatty acids methyl esters HODEs 15-LO 15-lipoxygenase metabolites linoleic endothelial cells leukocytes tumors inhibits inhibitors inhibition adhesion endothelium down regulation IRGpIIb/IIIa receptors lipophilic analytical standards |
16.549911602209
|
| 45220 |
13(S)-HpOTrE
Exclusive
|
|
67597-26-6 |
≥98%
|
|
✓ |
|
12.013922651934
|
13-s-hpotre
|
|
13-HpOTrEs monohydroperoxy fatty acids hydroperoxides 13S-HpOTrEs 13(S)-HpOTrEs PUFA soybeans LO-2 lipoxygenases linolenic 13S-hydroperoxy-9Z,11E,15Z-octadecatrienoic |
12.013922651934
|
| 90175 |
13(Z)-Docosenoic Acid
|
|
112-86-7 |
≥98%
|
|
|
|
2.449281767955
|
13-z-docosenoic-acid
|
Erucic Acid
|
fatty acids |
2.449281767955
|
| 10006998 |
(±)14,15-DiHETE
Exclusive
|
|
- |
≥98%
|
|
✓ |
2005-07-13
|
12.106672805402
|
-14-15-dihete
|
(±)14,15-dihydroxy-eicosa-5,8,11,17-Tetraenoic Acid
|
epoxygenases metabolites EPA eicosapentaenoic acids epoxidations hydroxylations w-3 .omega.-3 fatty acids marine organisms incubated rats livers microsomes colitis homogenates cytochromes P450-catlyzed epoxidations w-6 .omega.-6 double bonds conversion vicinal diols epoxides hydrolases excreted excretion humans ingesting fish oils supplements 14,15-dihete |
12.106672805402
|
| 10009286 |
14(15)-EET-SI
|
|
218461-97-3 |
≥95%
|
|
|
2007-05-14
|
23.609134438305
|
14-15-eet-si
|
14(15)-EET-sulfonimide; 14(15)-EpETrE-SI
|
arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF |
23.609134438305
|
| 10007527 |
14(15)-EpEDE
Exclusive New
|
|
351533-80-7 |
≥98%
|
|
✓ |
2012-03-09
|
51.217386433394
|
14-15-epede
|
14,15-Epoxyeicosadienoic Acid
|
epoxides epoxygenases DGLA dihomo- γ-linolenic acids eicosatrienoic ETA cytochromes P450 PUFA monoepoxides 14,15-EpEDE 14,15-EpED-8,11 gamma-linolenic g-linolenic .gamma.-linolenic epoxyeicosadienoic |
51.217386433394
|
| 10007528 |
14(15)-EpEDE methyl ester
Exclusive New
|
|
- |
≥90%
|
|
✓ |
2012-04-05
|
74.241295273173
|
14-15-epede-methyl-ester
|
14,15-Epoxyeicosadienoic Acid methyl ester
|
epoxide epoxygenase DGLA dihomo-γ-linolenic acid eicosatrienoic acid ETA cytochrome P450 |
74.241295273173
|
| 10009375 |
14(Z)-Eicosenoic Acid
|
|
- |
≥98%
|
|
|
2007-02-09
|
1.926086556169
|
14-z-eicosenoic-acid
|
|
MUFAs monounsaturated fatty acids marine sponges goldfish chain elongation 12(Z)-oleic |
1.926086556169
|
| 10141 |
15-deoxy-Δ12,14-Prostaglandin J2-biotin
|
|
- |
>98%
|
|
|
2005-10-11
|
20.766694495600
|
15-deoxy-12-14-prostaglandin-j2-biotin
|
15-deoxy-Δ12,14-PGJ2-biotin
|
affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides |
20.766694495600
|
| 10006692 |
(+)-15-epi Cloprostenol
|
|
54276-22-1 |
≥98%
|
|
|
2005-05-18
|
6.888674033149
|
-15-epi-cloprostenol
|
(+)-15(S)-Cloprostenol; D-Cloprostenol
|
prostaglandins F2.alpha. PGF2a analogs cloprostenols FP agonists 15(S) 15-epi C-15 epimers receptors 15b 15.beta.-hydroxy enantiomers ligands isomers |
6.888674033149
|
| 9000789 |
16-hydroxy Hexadecanoic Acid
|
|
506-13-8 |
≥98%
|
|
|
2011-08-31
|
1.431823204419
|
16-hydroxy-hexadecanoic-acid
|
Juniperic Acid; 16-Hydroxy Palmitic Acid
|
fatty acids palmitic metabolites metabolism cytochromes P450 CYP450 cutin plants animals |
1.431823204419
|
| 10006999 |
(±)17,18-DiHETE
Exclusive
|
|
- |
≥98%
|
|
✓ |
2005-07-13
|
9.208910812943
|
-17-18-dihete
|
(±)17,18-dihydroxy-eicosa-5,8,11,14-Tetraenoic Acid
|
EPAs eicosapentaenoic acids epoxidations hydroxylations epoxygenases metabolites w-3 .omega.-3 fatty marine organisms metabolites produced incubated rat tissues homogenates cynomolgus monkey seminal vesicles cytochrome P450-catalyzed double bond conversion vicinal diols epoxides hydrolases metabolized Gaeumannomyces graminis 116477-53-3 |
9.208910812943
|
| 9000346 |
17-keto-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid
Exclusive
|
|
- |
≥98%
|
|
✓ |
2009-04-01
|
90.646519337016
|
17-keto-4-z-7-z-10-z-13-z-15-e-19-z-docosahexaenoic-acid
|
17-keto-(4Z,7Z,10Z,13Z,15E,19Z)-DHA
|
keto fatty acids DHA lipoxygenase oxidation ω-3 aspirin COX-2 COX2 COX 2 anti-inflammatory antiinflammatory cardiovascular |
90.646519337016
|
| 9000347 |
17-keto-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
Exclusive
|
|
- |
≥95%
|
|
✓ |
2009-04-06
|
79.401104972375
|
17-keto-7-z-10-z-13-z-15-e-19-z-docosapentaenoic-acid
|
|
keto fatty acids DPA lipoxygenase oxidation ω aspirin COX-2 COX2 COX 2 anti-inflammatory antiinflammatory cardiovascular |
79.401104972375
|
| 90270 |
17-Octadecynoic Acid
|
|
34450-18-5 |
>98%
|
|
|
|
24.856519337017
|
17-octadecynoic-acid
|
ODYA; 17-ODA
|
acetylene omega-hydroxylase .omega.-hydroxylase w-hydroxylase inhibitors cytochrome P450 fatty acids analogs 20-hydroxylasae 17-oda 17-odya |
24.856519337017
|
| 10005099 |
17(R)-HDoHE
Exclusive
|
|
155976-53-7 |
≥98%
|
|
✓ |
2005-01-05
|
25.056148382005
|
17-r-hdohe
|
17(R)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry |
25.056148382005
|
| 10009799 |
17(S)-HDoHE
|
|
- |
≥98%
|
|
|
2007-03-12
|
13.789244935543
|
17-s-hdohe
|
17(S)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe |
13.789244935543
|
| 11009 |
18-methyl Eicosanoic Acid
New
|
|
36332-93-1 |
≥95%
|
|
|
2011-12-16
|
5.292077620898
|
18-methyl-eicosanoic-acid
|
18-MEA; Anteisoheneicosanoic Acid
|
hair hydrophobic epicuticle cosmetics human hydrophobicity surface additives cosmetics conditioning MEA 18MEA outer layers methyleicosanoic acids |
5.292077620898
|
| 10007001 |
(±)19,20-DiHDPA
|
|
- |
≥98%
|
|
|
2005-09-15
|
27.311981057616
|
-19-20-dihdpa
|
(±)19,20-DiHDoPE
|
epoxygenases metabolites DHA docosahexaenoic acids fatty w-3 omega-3 .omega.-3 neural tissues retina brain incubated incubation NADPH-supplemented nicotinamide adenine dinucleotide phosphates rat livers microsomes metabolized metabolizing monkey seminal vesicles cytochromes P450-catalyzed CYP450 epoxidation double bond vicinal diols epoxide hydrolases hydroxylation 138705-17-6 |
27.311981057616
|
| 10007766 |
19(S)-HETE
Exclusive
|
|
115461-40-0 |
≥98%
|
|
✓ |
2010-04-06
|
39.957384898710
|
19-s-hete
|
|
cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction Acids Hydroxyeicosatetraenoic
Hydroxyeicosatetraenoic Acids
HETE |
39.957384898710
|
| 10008869 |
1-Linoleoyl Glycerol
|
|
- |
>90%
|
|
|
2006-09-13
|
20.618047882136
|
1-linoleoyl-glycerol
|
1-LG
|
1LG 1-Linoleoyl-Glycerol lipids PAF-AH platelet-activating factors inhibits inhibitors inhibition fatty acids glycerols Saururus chinensis roots cholesterols antiatheogenic LP-PLA2 |
20.618047882136
|
| 10007912 |
20-carboxy Arachidonic Acid
Exclusive
|
|
79551-84-1 |
>98%
|
|
✓ |
2007-08-15
|
47.112430939226
|
20-carboxy-arachidonic-acid
|
20-COOH-AA
|
20-HETE metabolites PPAR.alpha. PPAR.gamma. vasorelaxation activators CYP4F3B hypertension cytochrome P450 CYP450 perioxisome proliferator activated receptor PPARs PPARalpha PPARgamma |
47.112430939226
|
| 90380 |
2-Fluoropalmitic Acid
|
|
16518-94-8 |
≥98%
|
|
|
|
53.486187845304
|
2-fluoropalmitic-acid
|
|
inhibitors sphingosine biosynthesis CoA synthases analogs inhibits fatty acids |
53.486187845304
|
| 90390 |
2-Hydroxymyristic Acid
|
|
2507-55-3 |
≥98%
|
|
|
|
14.272099447513
|
2-hydroxymyristic-acid
|
|
inhibitors inhibits myristoylation acylation proteins acids 2-hydroxytetradecanoic 2OHMRYA |
14.272099447513
|
| 10009651 |
2-thio-Acetyl MAGE
|
|
112014-15-0 |
≥97%
|
|
|
2007-02-22
|
8.737748618784
|
2-thio-acetyl-mage
|
|
KIAA1363 cancers colorimetric substrates activity inhibition inhibits inhibitory enzymatic activity |
8.737748618784
|
| 90500 |
3-Thiatetradecanoic Acid
|
|
116296-31-2 |
≥98%
|
|
|
2004-02-06
|
1.169668508287
|
3-thiatetradecanoic-acid
|
3-TDA
|
thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis |
1.169668508287
|
| 90312 |
4,5-dehydro Docosahexaenoic Acid
|
|
- |
≥98%
|
|
|
|
25.332228360957
|
4-5-dehydro-docosahexaenoic-acid
|
4,5-dehydro Cervonic Acid; 4,5-dehydro DHA
|
w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors |
25.332228360957
|
| 10004413 |
4-hydroperoxy 2-Nonenal
Exclusive
|
|
7439-43-2 |
≥95%
|
|
✓ |
2005-05-25
|
39.250872928177
|
4-hydroperoxy-2-nonenal
|
4-HpNE
|
free radicals peroxidation lipids oxidized w-6 .omega.-6 omega-6 PUFAs polyunsaturated fatty acids linoleics arachidonics oxidative stress cytotoxicity growth inhibiting activity genotoxicity chemotactic 4-HNE 4-hydroxy nonenals 4-OH-nonenal 4-hydroxynonenal hydroperoxides injury |
39.250872928177
|
| 90020 |
5,6-dehydro Arachidonic Acid
|
|
58688-54-3 |
>98%
|
|
|
|
1.927071823205
|
5-6-dehydro-arachidonic-acid
|
|
fatty acids PUFAs inhibitors 5-LO acetylene inhibits 5-lipoxygenases |
1.927071823205
|
| 10467 |
5,6-DiHETE
Exclusive
|
|
845673-97-4 |
≥97%
|
|
✓ |
2011-06-13
|
10.125051302288
|
5-6-dihete
|
|
eicosapentaenoic acids EPAs cytochromes P450 P-450 metabolites polyunsaturated fatty metabolites ω-3 omega epoxidation 5(6)-DiHETE DiHETEs epoxide hydrolases CYP450 |
10.125051302288
|
| 90114 |
5(6)-EpETE methyl ester
|
|
127716-49-8 |
≥98%
|
|
|
|
9.472685082873
|
5-6-epete-methyl-ester
|
5,6-epoxy Eicosatetraenoic Acid methyl ester; 5,6-EEQ methyl ester
|
EPA metabolites epoxygenase |
9.472685082873
|
| 90200 |
5,8,11-Eicosatriynoic Acid
|
|
13488-22-7 |
≥99%
|
|
|
|
17.439867403315
|
5-8-11-eicosatriynoic-acid
|
5,8,11-ETI
|
acetylene inhibitors lipoxygenase cyclooxygenase fatty acids |
17.439867403315
|
| 16300 |
5-iPF2α-VI
Exclusive
|
|
180469-63-0 |
≥95%
|
|
✓ |
2006-02-06
|
11.565193370165
|
5-ipf2-vi
|
iPF2α-I
|
marker oxidative injury 8-isoprostanes prostaglandins PGs free-radical lipids peroxidations ipf2a arachidonic acids polyunsaturated fatty stereo- regioisomeric oxidative stress Type VI internal lactones facilitates extraction purification pgf2a |
11.565193370165
|
| 10006654 |
5-iPF2α-VI-d11
|
|
- |
≥99% deuterated forms (d1-d11)
|
|
|
2005-03-17
|
122.834497237569
|
5-ipf2-vi-d11
|
|
isoprostanes peroxidation oxidative injury deuterateds deuteriums isotopes 8,12-isoprostanes iPF2alpha-VI-d11 prostaglandins iPF2a-VI-d11 urine peroxidative damage enantiomers stress |
122.834497237569
|
| 10009999 |
5(Z),11(Z),14(Z)-Eicosatrienoic Acid
|
|
7019-85-4 |
≥98%
|
|
|
2007-08-08
|
2.471284530387
|
5-z-11-z-14-z-eicosatrienoic-acid
|
Sciadonic Acid; 5,11,14,20:3
|
inflammation PUFA fatty acids MPSO maritime pine seed oil Pinus pinaster inflammatory (5z,8z,11z)-eicosa-5,8,11-trienoic acid |
2.471284530387
|
| 10010484 |
5(Z),14(Z)-Eicosadienoic Acid
Exclusive
|
|
122055-58-7 |
≥98%
|
|
✓ |
2008-11-21
|
21.262417127071
|
5-z-14-z-eicosadienoic-acid
|
|
fatty acids polyunsaturated PUFAs |
21.262417127071
|
| 90190 |
5(Z),8(Z),11(Z)-Eicosatrienoic Acid
|
|
20590-32-3 |
≥98%
|
|
|
|
5.314244935543
|
5-z-8-z-11-z-eicosatrienoic-acid
|
Mead Acid
|
fatty acids deficient PUFAs omega-3 omega-6 polyunsaturated ω-3 ω-6 |
5.314244935543
|
| 10742 |
5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6
Exclusive
|
|
- |
≥99% deuterated forms (d1-d6)
|
|
✓ |
2011-06-28
|
2.530957642725
|
5-z-8-z-11-z-eicosatrienoic-acid-d6
|
Mead Acid-d6
|
standards GC-MS GC/MS LC-MS LC/MS mass spectroscopy deuterium deuterateds fatty acids deficient PUFAs omega-3 omega-6 omega 6 omega 3 polyunsaturated ω-3 ω-6 ω3 ω6 ω 3 ω 6 |
2.530957642725
|
| 90195 |
5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide
|
|
169232-04-6 |
≥98%
|
|
|
|
8.987233319167
|
5-z-8-z-11-z-eicosatrienoic-acid-ethanolamide
|
Mead Acid Ethanolamide
|
cannabinoids neurotransmitter CB1 CB2 receptors ligands acids ethanolamides eicosatrienoyl fatty acids neurochemistry neuroscience ethanolamines |
8.987233319167
|
| 9000215 |
5(Z),8(Z),11(Z)-Eicosatrienoic Acid methyl ester
|
|
- |
≥98%
|
|
|
2010-11-29
|
10.848121546961
|
5-z-8-z-11-z-eicosatrienoic-acid-methyl-ester
|
Mead Acid methyl ester
|
polyunsaturated fatty acids PUFAs essential deficiency standards 20:3 (n-9) methyl ester |
10.848121546961
|
| 10009733 |
5(Z),8(Z),14(Z)-Eicosatrienoic Acid
|
|
90105-02-5 |
>98%
|
|
|
2007-08-09
|
1.486754143646
|
5-z-8-z-14-z-eicosatrienoic-acid
|
|
PUFAs fatty acids 5-LO 5LO RBL-1 RBL1 5-lipoxygenases substrates hydroxy hydroperoxy |
1.486754143646
|
| 62910 |
7-hydroxycoumarinyl Arachidonate
Exclusive
|
|
161180-11-6 |
≥98%
|
|
✓ |
|
30.091171270718
|
7-hydroxycoumarinyl-arachidonate
|
Umbelliferyl Arachidonate
|
fluorescent cPLA2s substrates 7-hydroxycoumarin fluorescence PLAs phospholipases 7-OH-coumarin fatty acids |
30.091171270718
|
| 10556 |
7-hydroxycoumarinyl-γ-Linolenate
|
|
161180-12-7 |
≥98%
|
|
|
2010-11-03
|
2.670828729282
|
7-hydroxycoumarinyl-linolenate
|
Umbelliferyl-γ-Linolenate
|
7-HC-γ-linolenate 7-HC-gamma-linolenate 7-HC-.gamma.-linolenate 7-HC-g-linolenate 7-hydroxy coumarin seven 7 hydroxy gamma .gamma. g γ substrates fluorogenic cPLAs cPLA2 phospolipase fatty acids FAAH enzyme activities activity |
2.670828729282
|
| 10878 |
7(R)-Maresin 1
New
|
|
1268720-28-0 |
≥95%
|
|
|
2012-02-01
|
136.325964929138
|
7-r-maresin-1
|
7(R)-MaR1
|
docosahexaenoic acids DHA macrophages zymosan inflammation phagocytosis fatty brain retina murine peritonitis FITC 7(R) maresin 1 mar 1 |
136.325964929138
|
| 10546 |
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
Exclusive
|
|
887752-13-8 |
≥98%
|
|
✓ |
2010-10-22
|
4.518093922651
|
7-s-17-s-dihydroxy-8-e-10-z-13-z-15-e-19-z-docosapentaenoic-acid
|
7(S),17(S)-hydroxy DPA
|
opxylipin docosanoid DPAs DHAs protectins D1 anti-inflammatory fatty acids |
4.518093922651
|
| 13161 |
7(S)-Maresin 1
Exclusive
|
|
1268720-66-6 |
≥95%
|
|
✓ |
2010-08-19
|
76.025180136701
|
7-s-maresin-1
|
7(S)-MaR1
|
docosahexaenoic acids DHA macrophages zymosan A inflammation phagocytosis lipids zymosan-A peritoneum FITC-labeled FITC labeled mouse murine mice 7,14-dihydroxy 14S-hydroperoxy 887752-49-0 inflammation antiinflammatory anti-inflammation antiinflammation Docosahexaenoic Acid |
76.025180136701
|
| 10007900 |
8,11,14-Eicosatriynoic Acid
Exclusive
|
|
34262-64-1 |
≥98%
|
|
✓ |
2007-03-12
|
16.707301002659
|
8-11-14-eicosatriynoic-acid
|
8,11,14-ETI
|
Cyclooxygenases COX 12-LO 15-LO 5-LO Inhibitor Fatty acids Acetylenic Lipoxygenases SRS-A FA |
16.707301002659
|
| 90100 |
8,11-Eicosadiynoic Acid
|
|
82073-91-4 |
≥95%
|
|
|
|
3.418139963167
|
8-11-eicosadiynoic-acid
|
EDYA
|
acetylene inhibitors delta-5-desaturase cyclooxygenases .DELTA.-5-desaturase D-5-desaturase inhibits fatty acids D5-desaturase |
3.418139963167
|
| 10009532 |
8(9)-EET-d11
|
|
- |
≥99% deuterated forms (d1-d11)
|
|
|
2008-03-25
|
11.298416206261
|
8-9-eet-d11
|
8(9)-EpETrE-d11
|
epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs deuterated racemic mixture |
11.298416206261
|
| 16854 |
8(Z),14(Z)-Eicosadienoic Acid
Exclusive
|
|
135498-07-6 |
≥95%
|
|
✓ |
2009-03-05
|
0.364475138121
|
8-z-14-z-eicosadienoic-acid
|
|
Eicosanoic acid Eicosadienoic acid (8Z,14Z) Fatty acid FA Desaturase eicosatrienoic acid vasodilator |
0.364475138121
|
| 90400 |
9,12-Octadecadiynoic Acid
|
|
2012-14-8 |
>98%
|
|
|
|
9.055248618784
|
9-12-octadecadiynoic-acid
|
Ro 3-1314
|
inhibitors lipoxygenases cyclooxygenases COX PGHS prostaglandin synthases inhibits COX-1 5-LO fatty acids |
9.055248618784
|
| 90370 |
9(E),11(E)-Conjugated Linoleic Acid
|
|
544-71-8 |
≥98%
|
|
|
|
24.232320441989
|
9-e-11-e-conjugated-linoleic-acid
|
Mangold's acid; Isolinoleic Acid; 9E,11E-CLA
|
trans-fatty acids PUFAs polyunsaturated antitumor anticarcinogenic |
24.232320441989
|
| 10008042 |
9-Nitrooleate
|
|
875685-44-2 |
≥98%
|
|
|
2006-08-11
|
28.305948434622
|
9-nitrooleate
|
9-nitro-9-trans-Octadecenoic Acid
|
oleic acids nitration 10-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes |
28.305948434622
|
| 10009215 |
9-OxoOTrE
|
|
125559-74-2 |
≥95%
|
|
|
2006-11-01
|
6.111505524862
|
9-oxootre
|
9-KOTrE; 9-KOTE
|
oxidation antimicrobial plants pathogenic microorganisms bacteria fungi fungus hydroperoxides linolenic acids oxylipins 9S-HpOTrEs 9-HpOTrEs 9(S)-HpOTrEs 9(S)HpOTrEs hydroperoxy 5-lipoxygenases fatty 5-LOs |
6.111505524862
|
| 10007417 |
9-Thiastearic Acid
|
|
106689-24-1 |
≥98%
|
|
|
2005-07-20
|
1.194226519337
|
9-thiastearic-acid
|
|
heteroatom-substituted fatty acids modulates extensions desaturating distribution phospholipids pools radiolabeled stearate oleate rat hepatocytes hepatoma cellshypolipidemic effects anti-obesity therapeutics |
1.194226519337
|
| 10008349 |
9(Z),11(E),13(E)-Octadecatrienoic Acid
Exclusive
|
|
506-23-0 |
≥98%
|
|
✓ |
2006-06-21
|
2.942799263352
|
9-z-11-e-13-e-octadecatrienoic-acid
|
α-Eleostearic Acid; α-ESA
|
PUFAs polyunsaturated fatty acids apoptosis DNA polymerase topoisomerase plant seed oils bitter gourd tung tumors growth suppressors colons cancers Caco-2 cells |
2.942799263352
|
| 10008350 |
9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester
|
|
42021-86-3 |
≥98%
|
|
|
2006-06-27
|
0.965745856354
|
9-z-11-e-13-e-octadecatrienoic-acid-ethyl-ester
|
Ethyl α-eleostearate; α-ESA ethyl ester
|
PUFAs polyunsaturated fatty acids apoptosis DNA polymerase topoisomerase plant seed oils bitter gourd tung tumors growth suppressors colons cancers Caco-2 cells |
0.965745856354
|
| 10008333 |
9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester
|
|
4175-47-7 |
≥98%
|
|
|
2006-06-27
|
0.965745856354
|
9-z-11-e-13-e-octadecatrienoic-acid-methyl-ester
|
α-ESA methyl ester; Methyl α-eleostearate
|
PUFAs polyunsaturated fatty acids apoptosis DNA polymerase topoisomerase plant seed oils bitter gourd tung tumors growth suppressors colons cancers Caco-2 cells |
0.965745856354
|
| 90140 |
9(Z),11(E)-Conjugated Linoleic Acid
|
|
2540-56-9 |
≥98%
|
|
|
|
14.785262430939
|
9-z-11-e-conjugated-linoleic-acid
|
Bovinic acid; 9Z,11E-CLA
|
PPAR.gamma. .DELTA.6-desaturase antioxidants antitumor 9Z,11E- octadecadienoic conjugated PPARgamma DELTA6- d6- fatty acids peroxisome proliferator-activated receptors |
14.785262430939
|
| 10008492 |
Adipose Triglyceride Lipase Blocking Peptide
|
|
- |
|
|
|
2006-06-27
|
1.265193370166
|
adipose-triglyceride-lipase-blocking-peptide
|
ATGL; TG-hydrolase inducible PLA2-ζ; Desnutrin
|
antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis |
1.265193370166
|
| 10006409 |
Adipose Triglyceride Lipase Polyclonal Antibody
|
|
- |
|
|
|
2005-11-23
|
9.941270718232
|
adipose-triglyceride-lipase-polyclonal-antibody
|
Phospholipase A2ζ; Desnutrin; ATGL
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting |
9.941270718232
|
| 90300 |
Adrenic Acid
|
|
28874-58-0 |
>98%
|
|
|
|
17.211975138121
|
adrenic-acid
|
|
polyunsaturated fatty acids PUFAs docosatetraenoic |
17.211975138121
|
| 10005223 |
AM1172
|
|
251908-92-6 |
>98%
|
|
|
2004-09-01
|
24.112353433011
|
am1172
|
|
cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry cannabinoids cbs synthetic |
24.112353433011
|
| 13144 |
Anacardic Acid
|
|
16611-84-0 |
≥98%
|
|
|
2010-02-12
|
5.862559731964
|
anacardic-acid
|
6-pentadecyl Salicylic Acid
|
HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 |
5.862559731964
|
| 9000339 |
Arachidic Acid
|
|
506-30-9 |
≥98%
|
|
|
2008-10-23
|
30.643856490007
|
arachidic-acid
|
Arachic Acid; n-Eicosanoic Acid; NSC 93983; C20:0; Icosanoic Acid
|
long-chain fatty acids triglyceride dietary fat cholesterol |
30.643856490007
|
| 90010 |
Arachidonic Acid
|
|
506-32-1 |
≥98%
|
|
|
|
68.865479363016
|
arachidonic-acid
|
|
fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential |
68.865479363016
|
| 10007466 |
Arachidonic Acid-biotin
|
|
- |
>98%
|
|
|
2005-11-30
|
26.445758133824
|
arachidonic-acid-biotin
|
|
fatty acids PUFAs polyunsaturated biotinylated affinity probes binding proteins cellular cells esterified membranes phospholipids regulated pathways substrates biosynthesis eicosanoids messengers receptor-stimulated release metabolisms re-uptake signalling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated |
26.445758133824
|
| 390010 |
Arachidonic Acid-d8
|
|
69254-37-1 |
≥99% deuterated forms (d1-d8)
|
|
|
|
209.218998618785
|
arachidonic-acid-d8
|
|
standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated |
209.218998618785
|
| 10007277 |
Arachidonic Acid-d8 Lipid Maps MS Standard
|
|
69254-37-1 |
≥99% deuterated forms (d1-d8)
|
|
|
2009-03-02
|
84.566885359116
|
arachidonic-acid-d8-lipid-maps-ms-standard
|
|
standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated |
84.566885359116
|
| 10008200 |
Arachidonic Acid ethyl ester
|
|
1808-26-0 |
>98%
|
|
|
2006-05-05
|
9.764646408839
|
arachidonic-acid-ethyl-ester
|
Ethyl Arachidonate
|
PUFAs polyunsaturated fatty acids arachidonates lipophilic diets dietary cells exogenous cytosolic calcium Ca2+ pancreatic acinar ethanol FAEE injury essential |
9.764646408839
|
| 10007268 |
Arachidonic Acid Lipid Maps MS Standard
|
|
506-32-1 |
≥98%
|
|
|
2009-07-06
|
18.887808471454
|
arachidonic-acid-lipid-maps-ms-standard
|
|
fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards |
18.887808471454
|
| 90014 |
Arachidonic Acid methyl ester
|
|
2566-89-4 |
>98%
|
|
|
|
25.065041436464
|
arachidonic-acid-methyl-ester
|
Methyl Arachidonate
|
PUFA FAME polyunsaturated fatty acids esters GC exogenous 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic diets dietary arachidonates essential |
25.065041436464
|
| 390014 |
Arachidonic Acid methyl ester-d8
Exclusive
|
|
- |
≥99% deuterated forms (d1-d8)
|
|
✓ |
2010-02-12
|
17.645138121547
|
arachidonic-acid-methyl-ester-d8
|
Methyl Arachidonate-d8
|
PUFA FAME polyunsaturated fatty acids esters GC exogenous 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic diets dietary arachidonates essential deuterateds deuteriums standards LC/MS MS mass spectrometry GC/MS LC-MS GC-MS |
17.645138121547
|
| 90010.1 |
Arachidonic Acid (peroxide free)
|
|
506-32-1 |
>98%
|
|
|
|
64.558646408840
|
arachidonic-acid-peroxide-free
|
|
fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential |
64.558646408840
|
| 10006835 |
Arachidonic Acid Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
34.981104972375
|
arachidonic-acid-quant-pak
|
|
Quant-PAKs fatty acids PUFAs polyunsaturated standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated packs |
34.981104972375
|
| 10006607 |
Arachidonic Acid (sodium salt)
|
|
6610-25-9 |
>98%
|
|
|
2005-03-08
|
24.705895027624
|
arachidonic-acid-sodium-salt
|
Sodium Arachidonate
|
PUFAs AA diets EFA w-6 omega-6 .omega.-6 polyunsaturated fatty acids deficiency biosynthesis eicosanoids signalling inflammations |
24.705895027624
|
| 90050 |
Arachidonoyl Ethanolamide
|
|
94421-68-8 |
≥98%
|
|
|
|
44.704675456451
|
arachidonoyl-ethanolamide
|
Anandamide; AEA
|
cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology |
44.704675456451
|
| 390050 |
Arachidonoyl Ethanolamide-d8
|
|
- |
≥99% deuterated forms (d1-d8)
|
|
|
|
42.214751381215
|
arachidonoyl-ethanolamide-d8
|
Anandamide-d8; AEA-d8
|
deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology |
42.214751381215
|
| 10007270 |
Arachidonoyl Ethanolamide Lipid Maps MS Standard
|
|
94421-68-8 |
≥98%
|
|
|
2009-02-18
|
7.096138971526
|
arachidonoyl-ethanolamide-lipid-maps-ms-standard
|
AEA; Anandamide
|
cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards |
7.096138971526
|
| 10007531 |
Arachidonoyl Glycine-d8
|
|
- |
≥99% deuterated forms (d1-d8)
|
|
|
2005-09-13
|
17.205649171270
|
arachidonoyl-glycine-d8
|
N-Arachidonyl Glycine-d8; NAGly-d8
|
deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience |
17.205649171270
|
| 9000325 |
Arachidoyl glycine
|
|
617703-96-5 |
≥98%
|
|
|
2008-12-02
|
0.579248618784
|
arachidoyl-glycine
|
|
arachidic acid glycine fatty acids PUFAs polyunsaturated fatty acids |
0.579248618784
|
| 10007927 |
AUDA
Exclusive
|
|
479413-70-2 |
>98%
|
|
✓ |
2006-04-28
|
24.837419889502
|
auda
|
|
epoxides hydrolases hypertension dihydroxy-eicosatrienoic acids DHETs 11(12)-EETs 14(15)-EETs blood pressure soluble sEH inhibits inhibitors inhibition peroxisome proliferator-activated receptors PPARalpha PPAR.alpha. DiHETrEs EpETrEs endocrinology |
24.837419889502
|
| 70770 |
BAY-u9773
|
|
154978-38-8 |
>95%
|
|
|
2005-03-30
|
42.649613259668
|
bay-u9773
|
|
asthma leukotrienes CysLTs allergy antagonists cysteinyls receptors 7-transmembranes pranlukasts montelukasts CysLT2 CysLT1 CysLT-1 CysLT-2 |
42.649613259668
|
| 10155 |
BM 567
|
|
284464-77-3 |
>98%
|
|
|
2005-03-31
|
43.370676795580
|
bm-567
|
|
platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege |
43.370676795580
|
| 10005270 |
C75
|
|
191282-48-1 |
≥98%
|
|
|
2004-09-22
|
23.309447513812
|
c75
|
|
inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology |
23.309447513812
|
| 71652 |
CAY10401
|
|
288862-89-5 |
>98%
|
|
|
2005-02-02
|
7.964372007366
|
cay10401
|
|
FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry cannabinoids cbs synthetic |
7.964372007366
|
| 10004259 |
CAY10429
|
|
22972-55-0 |
>98%
|
|
|
2005-02-09
|
32.021406328478
|
cay10429
|
Abnormal Cannabidiol; Abn-CBD
|
endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neuroscience |
32.021406328478
|
| 10005067 |
CAY10434
|
|
- |
>98%
|
|
|
2005-01-19
|
13.084198895027
|
cay10434
|
|
CYP20-HETE CYP450 cytochromes renal kidney metabolites arachidonic acid enzymes CYP4A11 inhibits inhibitors inhibition imidazoles |
13.084198895027
|
| 10005072 |
CAY10455
|
|
290374-09-3 |
>98%
|
|
|
2004-11-09
|
8.140732044199
|
cay10455
|
SKM 4-45-1
|
anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience |
8.140732044199
|
| 10006400 |
CAY10462
|
|
502656-68-0 |
>98%
|
|
|
2005-01-19
|
30.100883977900
|
cay10462
|
|
hydroxy eicosatetraenoic acids 20-HETEs CYP450 cytochromes renal kidney metabolites arachidonic enzymes CYP4A inhibits inhibitors inhibition metabolism CAY10434 dihydrochlorides selective selectivity synthases |
30.100883977900
|
| 10009167 |
CAY10509
|
|
1245699-47-1 |
≥98%
|
|
|
2006-10-25
|
87.593895027624
|
cay10509
|
|
FP PGF2.alpha. glaucoma compound A receptors agonists intraocular pressure glaucoma IOP ophthalmology |
87.593895027624
|
| 10562 |
CAY10631
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-02-10
|
0.281767955801
|
cay10631
|
|
Very long chain fatty acids docosahexaenoic elongases retinas macular diseases rhodopsin |
0.281767955801
|
| 10497 |
CAY10632
Exclusive
|
|
105517-82-6 |
≥98%
|
|
✓ |
2011-03-14
|
0.348066298342
|
cay10632
|
|
very long chain fatty acids VLCPUFA retinas macular diseases ELOVL4 dotriacontahexaenoic FA-4 FA4 retinal macular degeneration |
0.348066298342
|
| 10005647 |
Cerulenin
|
|
17397-89-6 |
≥98%
|
|
|
2004-09-01
|
30.217458563535
|
cerulenin
|
|
tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity D02.065.327 |
30.217458563535
|
| 10007171 |
Cetaben
|
|
55986-43-1 |
≥98%
|
|
|
2005-11-11
|
1.577348066298
|
cetaben
|
Hexadecylamino-p-amino Benzoic Acid
|
clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology |
1.577348066298
|
| 10010180 |
cis-12-Octadecenoic Acid methyl ester
|
|
2733-86-0 |
>96%
|
|
|
2008-01-15
|
0.518674033149
|
cis-12-octadecenoic-acid-methyl-ester
|
|
fatty acids cis-12-octadecenoate lipids monounsaturated C18 isomers soluble solubilty C-18 |
0.518674033149
|
| 10007289 |
cis-4,10,13,16-Docosatetraenoic Acid
Exclusive
|
|
122068-08-0 |
≥98%
|
|
✓ |
2006-07-19
|
35.594640883978
|
cis-4-10-13-16-docosatetraenoic-acid
|
|
PUFAs polyunsaturated fatty acids rat testis lipids |
35.594640883978
|
| 10006866 |
cis-4,10-13,16-Docosatetraenoic Acid methyl ester
|
|
- |
≥98%
|
|
|
2006-07-19
|
35.609005524862
|
cis-4-10-13-16-docosatetraenoic-acid-methyl-ester
|
|
methyl esters polyunsaterated fatty acids PUFAs rat testis lipids lipophilic |
35.609005524862
|
| 10007290 |
cis-7-Hexadecenoic Acid
|
|
2416-19-5 |
≥98%
|
|
|
2006-02-21
|
2.958821362798
|
cis-7-hexadecenoic-acid
|
|
monounsaturated fatty acids cellular membranes autotrophic bacterial genera populations natural environments mining lakes cultures sulfates biofilters sulfide-oxidizing organisms strains Nitrospira nitrates |
2.958821362798
|
| 10006864 |
cis-7-Hexadecenoic Acid methyl ester
|
|
56875-67-3 |
≥98%
|
|
|
2006-02-21
|
2.162946593001
|
cis-7-hexadecenoic-acid-methyl-ester
|
cis-7-Hexadecenoate methyl ester
|
esters monounsaturated fatty acids cellular membranes autotrophic bacterial genera populations natural environments mining lakes cultures sulfates biofilters sulfide-oxidizing organisms strains Nitrospira nitrates |
2.162946593001
|
| 71430 |
cis-Parinaric Acid
|
|
18427-44-6 |
>98% (may contain up to 5% trans-Parinaric acid)
|
|
|
|
5.274217311234
|
cis-parinaric-acid
|
α-Parinaric Acid
|
phospholipases fluorescent fluorescence lipoproteins labelling detection makita tree polyunsaturated fatty acids pufa tatraenes lipid peroxidation 9z,11e,13e,15z-octadecatetraenoic |
5.274217311234
|
| 10006189 |
cis-Parinaric Acid methyl ester
Exclusive
|
|
26474-40-8 |
>98%
|
|
✓ |
2008-05-19
|
6.013812154696
|
cis-parinaric-acid-methyl-ester
|
α-Parinaric Acid methyl ester
|
phospholipases fluorescent fluorescence lipoproteins detection makita tree polyunsaturated fatty acids pufas tetraene lipid peroxidation 9z,11e,13e,15z-octadecatetraenoic methyl esters |
6.013812154696
|
| 10008123 |
cis-Δ2-11-methyl-Dodecenoic Acid
|
|
677354-23-3 |
≥98%
|
|
|
2006-04-20
|
25.851657458563
|
cis-2-11-methyl-dodecenoic-acid
|
|
microbial extracellular signaling molecules prokaryotes eukaryotes cells diffusible factors DSF fungal fungus communication systems bioassays biosensors conformational isomers fatty acids signalling cell-cell trans-.DELTA.2-11-methyl-dodecenoic trans-d2-11-methyl-dodecenoic trans-delta2-11-methyl-dodecenoic cis-d2-11-methyl-dodecenoic cis-delta2-11-methyl-dodecenoic bacterial pathogens microbacterium C. albicans |
25.851657458563
|
| 10007133 |
CMPF
Exclusive
|
|
86879-39-2 |
≥98%
|
|
✓ |
2005-11-11
|
20.600478821362
|
cmpf
|
|
thyroxines T3 T4 furan fatty acids inactive primary secreted products thyroid glands converted active hormones triiodothyrodinine enzymes 5'-deiodinase albumin-bound furanoids accumulates serums uremic patients inhibits cellular transport subsequent deiodination displaces competitive binding molecules acidic drugs free oleic endocrinology |
20.600478821362
|
| 10120 |
CP 24,879 (hydrochloride)
|
|
10141-51-2 |
≥98%
|
|
|
|
7.046519337016
|
cp-24-879-hydrochloride
|
p-(Isopentyloxy)-aniline
|
.DELTA.5/.DELTA.6-desaturases inhibitors inhibits DELTA5/DELTA6-desaturases D5/D6-desaturases fatty acids hydrochlorides CP-24879 |
7.046519337016
|
| 10007923 |
CUDA
Exclusive
|
|
479413-68-8 |
≥98%
|
|
✓ |
2006-04-28
|
22.581843922652
|
cuda
|
|
epoxides hydrolases hypertension dihydroxy eicosatrienoic acids DiHETrEs DHETs 11(12)-EETs 14(15)-EETs EpETrEs blood pressure soluble sEH inhibits inhibitors inhibition peroxisome proliferator-activated receptors PPARalpha PPAR.alpha. activates activation endocrinology |
22.581843922652
|
| 10005188 |
DAUDA
|
|
73025-02-2 |
≥98%
|
|
|
2007-05-17
|
1.099502762431
|
dauda
|
11-(Dansylamino)undecanoic Acid
|
fluorescent fatty acids S. mansoni Schistosoma mansoni Sm14 fluorescence 11-(dansylamino)undecanoic binding proteins |
1.099502762431
|
| 10018 |
DDMS
|
|
206052-03-1 |
>98%
|
|
|
2005-02-22
|
9.518784530387
|
ddms
|
Dibromo-dodecenyl-methylsulfimide
|
20-HETEs inhibits inhibitors inhibition synthesis CYP450-4A2 renal hypotension vascular homeostasis circulation kidneys vasodilation vasodilators NONOates CYP4A2 donors cytochrome |
9.518784530387
|
| 90230 |
Dihomo-γ-Linolenic Acid
|
|
1783-84-2 |
>98%
|
|
|
|
18.844375076734
|
dihomo-linolenic-acid
|
DGLA
|
fatty acids PUFAs primrose .omega.-6 omega-6 polyunsaturated dihomo-g-linolenic dihomo-.gamma.-linolenic dihomo-gamma-linolenic w-6 |
18.844375076734
|
| 10458 |
Dihomo-γ-Linolenic Acid-d6
Exclusive
|
|
- |
≥99% deuterated forms (d1-d6)
|
|
✓ |
2011-06-13
|
13.281111111111
|
dihomo-linolenic-acid-d6
|
DGLA-d6
|
deuterated LC/MS GC-MS LC-MS mass spectrometry polyunsaturated dihomo-g-linolenic dihomo-γ-linolenic dihomo-gamma-linolenic omega-6 ω-6 fatty acids antagonists arachidonic receptors LTB4 deuterium |
13.281111111111
|
| 90236 |
Dihomo-γ-Linolenic Acid ethyl ester
|
|
- |
>98%
|
|
|
|
9.418453038674
|
dihomo-linolenic-acid-ethyl-ester
|
Ethyl DGLA
|
fatty acids PUFAs primrose polyunsaturated dihomo-g-linolenic dihomo-.gamma.-linolenic dihomo-gamma-linolenic esters fatty acids |
9.418453038674
|
| 10006580 |
Dihomo-γ-Linolenic Acid methyl ester
|
|
21061-10-9 |
>98%
|
|
|
2005-03-04
|
15.406009821976
|
dihomo-linolenic-acid-methyl-ester
|
Methyl DGLA
|
fatty acids PUFAs primrose .omega.-6 omega-6 polyunsaturated dihomo-g-linolenic dihomo-.gamma.-linolenic dihomo-gamma-linolenic w-6 |
15.406009821976
|
| 10006305 |
D-NMAPPD
Exclusive
|
|
35922-06-6 |
≥98%
|
|
✓ |
2005-02-23
|
16.744126481115
|
d-nmappd
|
CAY10466; (1R,2R)-B13
|
ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces |
16.744126481115
|
| 90310 |
Docosahexaenoic Acid
|
|
6217-54-5 |
≥98%
|
|
|
|
91.329337016574
|
docosahexaenoic-acid
|
DHA; Cervonic Acid
|
polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 neurochemistry c22:6 22:6 |
91.329337016574
|
| 10005057 |
Docosahexaenoic Acid-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
2005-03-16
|
218.188360957642
|
docosahexaenoic-acid-d5
|
Cervonic Acid-d5; DHA-d5
|
standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension |
218.188360957642
|
| 9090310 |
Docosahexaenoic Acid ethyl ester
|
|
1020718-25-5 |
≥98%
|
|
|
2009-01-15
|
68.145290055248
|
docosahexaenoic-acid-ethyl-ester
|
DHA ethyl ester; Cervonic Acid ethyl ester
|
fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism |
68.145290055248
|
| 10006865 |
Docosahexaenoic Acid methyl ester
|
|
2566-90-7 |
≥98%
|
|
|
2005-09-06
|
87.794162062614
|
docosahexaenoic-acid-methyl-ester
|
Cervonic Acid methyl ester; DHA methyl ester
|
polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina |
87.794162062614
|
| 10006829 |
Docosahexaenoic Acid Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
50.848740331491
|
docosahexaenoic-acid-quant-pak
|
DHA Quant-PAK; Cervonic Acid Quant-PAK
|
Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs |
50.848740331491
|
| 9000328 |
Docosahexaenoyl Glycine
Exclusive
|
|
132850-40-9 |
≥98%
|
|
✓ |
2009-01-28
|
18.429848066298
|
docosahexaenoyl-glycine
|
|
polunsaturated fatty acids PUFAs docosahexaenoic DHA glycines fish oils ALA brain retina neuron neuronal membrane ω-3 α-linolenic |
18.429848066298
|
| 9000338 |
Docosanoic acid
|
|
112-85-6 |
≥98%
|
|
|
2008-10-20
|
3.363903383125
|
docosanoic-acid
|
DCA; Behenic Acid; NSC 32364; C22:0
|
fatty acids long-chains triglycerides dietary fats cholesterol LDLs |
3.363903383125
|
| 90165 |
Docosapentaenoic Acid
|
|
24880-45-3 |
≥98%
|
|
|
|
27.813879680785
|
docosapentaenoic-acid
|
|
fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 dpa |
27.813879680785
|
| 90385 |
Docosatetraenoyl Ethanolamide
|
|
150314-35-5 |
≥98%
|
|
|
|
6.723041923952
|
docosatetraenoyl-ethanolamide
|
DEA
|
endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
6.723041923952
|
| 90170 |
Docosatrienoic Acid
|
|
28845-86-5 |
≥98%
|
|
|
|
31.262480049110
|
docosatrienoic-acid
|
|
polyunsaturatd fatty acids PUFAs omega-3 .omega.-3 |
31.262480049110
|
| 90110 |
Eicosapentaenoic Acid
|
|
10417-94-4 |
≥98%
|
|
|
|
66.381818181818
|
eicosapentaenoic-acid
|
Timnodonic Acid; EPA
|
fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 C20:5 20:5 |
66.381818181818
|
| 10005056 |
Eicosapentaenoic Acid-d5
|
|
145191-14-6 |
≥99% deuterated forms (d1-d5)
|
|
|
2005-08-30
|
291.556055248619
|
eicosapentaenoic-acid-d5
|
EPA-d5; Timnodonic Acid-d5
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory |
291.556055248619
|
| 10008884 |
Eicosapentaenoic Acid ethyl ester
|
|
86227-47-6 |
≥98%
|
|
|
2009-01-29
|
70.995414364641
|
eicosapentaenoic-acid-ethyl-ester
|
EPA-EE; EPA ethyl ester
|
fish oils anti-inflammatory anitinflammatory cardiovascular polyunsaturated fatty acids PUFAs EPAs nutrition oxidation competitive inhibitors inhibits inhibition metabolism cholesterol triglycerides insulin resistance adiponectin high fat diet high-fat TNFα |
70.995414364641
|
| 9000295 |
Eicosapentaenoic Acid methyl ester
|
|
2734-47-6 |
≥98%
|
|
|
2011-10-07
|
53.386786372007
|
eicosapentaenoic-acid-methyl-ester
|
EPA methyl ester
|
vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs |
53.386786372007
|
| 90110.1 |
Eicosapentaenoic Acid (peroxide free)
|
|
10417-94-4 |
≥98%
|
|
|
|
102.968858195211
|
eicosapentaenoic-acid-peroxide-free
|
Timnodonic Acid (peroxide free); EPA (peroxide free)
|
fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 |
102.968858195211
|
| 13048 |
Eicosapentaenoic Acid Quant-PAK
|
|
- |
|
|
|
2008-07-28
|
49.068370165746
|
eicosapentaenoic-acid-quant-pak
|
Timnodonic Acid Quant-PAK; EPA Quant-PAK
|
Quant-PAKs EPA EPA-d5 EPAd5 internal standards deuterated GC/MS GC-MS LC/MS LC-MS mass quantpak spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory packs |
49.068370165746
|
| 90120 |
Eicosatetraynoic Acid
|
|
1191-85-1 |
>98%
|
|
|
|
6.291104972375
|
eicosatetraynoic-acid
|
ETYA
|
inhibitors inhibits lipoxygenases cyclooxygenases prostaglandin h synthases cox lo acetylene PPAR ligands peroxisome proliferator-activated receptors fatty acids |
6.291104972375
|
| 90250 |
Elaidic Acid
|
|
112-79-8 |
≥98%
|
|
|
|
3.028121546961
|
elaidic-acid
|
trans-Oleic Acid
|
trans-fatty acids |
3.028121546961
|
| 10006874 |
Ethyl Tricosanoate
|
|
18281-07-7 |
≥98%
|
|
|
2006-07-25
|
8.918453038674
|
ethyl-tricosanoate
|
|
fatty acids saturated esters standards hemolytic Staphylococcus aureus delta-toxin erythrocytes liverwort Conocephalum conicum |
8.918453038674
|
| 10005196 |
FAAH Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2008-09-05
|
96.643796369377
|
faah-inhibitor-screening-assay-kit
|
Fatty Acid Amide Hydrolase Inhibitor Screening Assay Kit
|
neurochemistry neuroscience endocannabinoids lipid signaling regulatory arachidonoylethanolamides AEAs 2-arachidonoyl glycerol 2-AG G Protein Coupling Receptors GPCRs CB1 motor controls cognition emotional responses homeostasis CB2 peripheral tissues modulators autonomic nervous systems immune microcirculation enzymes fatty acids amides hydrolases monoacylglycerols lipases MGL MAGL serines inhibitors pain obesity neurological diseases agonists fluorescence-based screening hydrolyzes AMC-arachidonoyl 7-amino-4-methylcoumarin fluorophores assays kits |
96.643796369377
|
| 10009547 |
FABP1 (human recombinant)
Exclusive
|
|
- |
>90%
|
|
✓ |
2007-09-04
|
4.566543891958
|
fabp1-human-recombinant
|
Liver-FABP; L-FABP; Fatty Acid Binding Protein
|
proteins metabolism cellular membranes FABP-1 FABPs fatty acids bladders carcinoma renal failure LFABP livers kidneys atherosclerosis endocrinology |
4.566543891958
|
| 10005200 |
FABP1 (rat recombinant)
|
|
- |
≥95%
|
|
|
2005-07-29
|
5.750127496812
|
fabp1-rat-recombinant
|
Liver-Fatty Acid Binding Protein; Fatty Acid Binding Protein 1; Liver-FABP; L-FABP
|
protein-only proteins cytosolic fatty acids antiparallel .beta. strands barrel expression hepatoblastoma hepatocellular carcinomas tumors markers liver kidney injury fluorescence displacement assay fluorescent analogue 11-(Dansylamino)undecanoic DAUDA arachidonic oleic pocket atherosclerosis endocrinology |
5.750127496812
|
| 10009548 |
FABP2 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-02-24
|
5.998793738489
|
fabp2-human-recombinant
|
Intestinal-FABP; Fatty Acid Binding Protein 2; I-FABP
|
cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology |
5.998793738489
|
| 10007938 |
FABP2 (rat recombinant)
|
|
- |
≥95%
|
|
|
2005-12-16
|
3.769083793738
|
fabp2-rat-recombinant
|
Fatty Acid Binding Protein 2; I-FABP; Intestinal-FABP
|
protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology |
3.769083793738
|
| 10007432 |
FABP3 (human recombinant)
|
|
- |
≥95%
|
|
|
2005-07-27
|
9.298664825046
|
fabp3-human-recombinant
|
Heart-FABP; Fatty Acid Binding Protein-3; H-FABP
|
protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology |
9.298664825046
|
| 10006248 |
FABP4 Blocking Peptide
|
|
- |
>95%
|
|
|
2004-11-15
|
5.407495395948
|
fabp4-blocking-peptide
|
Fatty Acid Binding Protein 4; AFABP; ALBP; aP2
|
peptides adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARg agonists insulin WB western blots ICC immunocytochemistry hyperinsulinemia deficiency controls immunoblotting atherosclerosis |
5.407495395948
|
| 10009549 |
FABP4 (human recombinant)
|
|
- |
≥90%
|
|
|
2007-06-15
|
16.343603909902
|
fabp4-human-recombinant
|
A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein
|
cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology |
16.343603909902
|
| 9001068 |
FABP4 (human recombinant) FITC conjugated
|
|
- |
≥95%
|
|
|
2011-08-23
|
6.631610102604
|
fabp4-human-recombinant-fitc-conjugated
|
ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4
|
fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 |
6.631610102604
|
| 10010463 |
FABP4 (human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-10-23
|
3.441008287292
|
fabp4-human-recombinant-western-ready-control
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting |
3.441008287292
|
| 10005191 |
FABP4 (mouse recombinant)
|
|
- |
≥95%
|
|
|
2005-07-27
|
6.236795580110
|
fabp4-mouse-recombinant
|
Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP
|
protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology |
6.236795580110
|
| 10009676 |
FABP4 (mouse recombinant) Western Ready Control
|
|
- |
|
|
|
2007-04-30
|
2.515782688766
|
fabp4-mouse-recombinant-western-ready-control
|
ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis |
2.515782688766
|
| 10004944 |
FABP4 Polyclonal Antibody
|
|
- |
|
|
|
2004-11-05
|
12.961649565904
|
fabp4-polyclonal-antibody
|
Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP
|
atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting |
12.961649565904
|
| 10010364 |
FABP5 (human recombinant)
|
|
- |
≥95%
|
|
|
2007-08-08
|
10.600895027624
|
fabp5-human-recombinant
|
Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP
|
proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology |
10.600895027624
|
| 10007433 |
FABP5 (mouse recombinant)
|
|
- |
≥95%
|
|
|
2005-07-29
|
3.242867905575
|
fabp5-mouse-recombinant
|
Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP
|
protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry |
3.242867905575
|
| 10009551 |
FABP7 (human recombinant)
|
|
- |
≥90%
|
|
|
2007-06-27
|
2.568988525286
|
fabp7-human-recombinant
|
B-FABP; Brain-FABP; Fatty Acid Binding Protein 7
|
cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology |
2.568988525286
|
| 10010183 |
Fatty Acid Amide Hydrolase (human recombinant)
|
|
- |
Whole-cell lysate
|
|
|
2008-11-05
|
41.269936858721
|
fatty-acid-amide-hydrolase-human-recombinant
|
FAAH (human recombinant)
|
FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases active |
41.269936858721
|
| 10010182 |
Fatty Acid Amide Hydrolase Western Ready Control
|
|
- |
66 kDa (His-tagged), 63 kDa (native)
|
|
|
2007-07-06
|
6.701616022099
|
fatty-acid-amide-hydrolase-western-ready-control
|
Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase
|
fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors |
6.701616022099
|
| 10008188 |
Fatty Acid ethyl ester Standard Pack
|
|
- |
≥98%
|
|
|
2006-06-20
|
5.381662983425
|
fatty-acid-ethyl-ester-standard-pack
|
|
acids esters analytical |
5.381662983425
|
| 10504 |
Fatty Acid Screening Library (96-Well)
|
|
- |
|
|
|
2009-12-04
|
31.630749802683
|
fatty-acid-screening-library-96-well
|
|
Fatty acids FAs |
31.630749802683
|
| 10008907 |
GW 9508
|
|
885101-89-3 |
≥98%
|
|
|
2007-05-14
|
22.284447513812
|
gw-9508
|
|
agonists GPR40 GPR120 G protein receptors fatty acid glucose insulin MIN6 coupled endocrinology GW9508 |
22.284447513812
|
| 10670 |
Heneicosapentaenoic Acid
New
|
|
24257-10-1 |
≥95%
|
|
|
2012-05-01
|
105.555555555555
|
heneicosapentaenoic-acid
|
HPA
|
fatty acids lipids cyclooxygenases 5-lipoxygenases prostaglandins H PGH synthases PGHS DHA COX 5-LO 5-LOX EPA arachidonic Bryopsis B. pennata fish oils eicosapentaenoic docosahexaenoic linoleic acid green alga algea DELTA6 .DELTA.6 Δ6 DELTA-6 .DELTA.-6 Δ-6 DELTA 6 .DELTA. Δ positions omega-3 .omega.-3 ω-3 omega3 .omega.3 ω3 omega 3 .omega. ω phospholipids triacylglycerols in vivo synthesis |
105.555555555555
|
| 10570 |
Heneicosapentaenoic Acid-d6
|
|
- |
≥99% deuterated forms (d1-d6)
|
|
|
2010-12-13
|
37.391514903485
|
heneicosapentaenoic-acid-d6
|
|
24257-10-1 c21:5 C-21:5 C 21:5 omega-3 .omega.-3 w-3 deterateds deuteriums standards mass spectrometry LC/MS GC/MS LC-MS GC-MS MS |
37.391514903485
|
| 11622 |
Heneicosapentaenoic Acid methyl ester
Exclusive New
|
|
65919-53-1 |
≥98%
|
|
✓ |
2012-04-23
|
101.111111111110
|
heneicosapentaenoic-acid-methyl-ester
|
HPA methyl ester
|
fatty acids EPA DHA arachidonic linoleic PGH synthases 5-LO prodrugs 5-LOX LO LOX prostaglandins PGs HPA Bryopsis pennata Lamouroux green algae fish oils eicosapentaenoic docosahexaenoic phospholipids 5-lipoxygenases 5 lipoxygenases |
101.111111111110
|
| 10006695 |
HEPC
|
|
60793-01-3 |
≥95%
|
|
|
2005-03-29
|
3.870508287293
|
hepc
|
2-Hexadecanoylthio-1-Ethylphosphorylcholine
|
PLA2 phospholipases substrates thiesters PL Ellman's reagent colorimetric analogs glyceerophospholipids activity phosphatidylcholine Type II porcine pancreatic bee venoms snake |
3.870508287293
|
| 90342 |
Heptadecanoyl Ethanolamide
|
|
- |
≥98%
|
|
|
|
7.549571823204
|
heptadecanoyl-ethanolamide
|
|
pea cannabinoids palmitoyl ethanolamides anandamides neurochemistry neuroscience ethanolamines |
7.549571823204
|
| 75780 |
HET0016
|
|
339068-25-6 |
≥98%
|
|
|
2005-01-31
|
54.900193370165
|
het0016
|
N-hydroxy-N'-(4-n-butyl-2-methylphenyl)Formamidine
|
20-HETEs kidney cytochromes CYP450 hypertension cerebral vascular diseases metabolites arachidonic acids liver CYP4F inhibitors inhibition inhibits CYP4A CYP2C9 CYP2D6 CYP3A4 cyclooxygenases COX PGHS prostaglandins synthases EETs epoxyeicosatrienoic |
54.900193370165
|
| 13354 |
Hexacosanoic Acid
|
|
506-46-7 |
≥98%
|
|
|
2009-07-24
|
6.570643714616
|
hexacosanoic-acid
|
Cerotic Acid; NSC 4205; Ceric Acid
|
fatty acids very long chain very-long-chain peroxisomes peroxisomals disorders adrenoleukodystrophy atherosclerosis metabolic syndromes red blood cells plasma ceratinic acids cerinic cerylic n-hexacosanoic cerolic acid |
6.570643714616
|
| 10008661 |
JP104
Exclusive
|
|
- |
≥98%
|
|
✓ |
2006-09-05
|
7.391034655951
|
jp104
|
|
click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry |
7.391034655951
|
| 10008660 |
JP83
|
|
887264-44-0 |
≥98%
|
|
|
2006-08-30
|
6.974116022099
|
jp83
|
|
FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB597 acyl anandamide AEA esters unsaturated carbamates arachidonoyl ethanolamides neurochemistry |
6.974116022099
|
| 10006626 |
Lauric Acid
|
|
143-07-7 |
>98%
|
|
|
2005-04-20
|
15.110616729759
|
lauric-acid
|
|
saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 |
15.110616729759
|
| 10008203 |
Lauric Acid ethyl ester
|
|
106-33-2 |
>98%
|
|
|
2006-05-05
|
1.619921731123
|
lauric-acid-ethyl-ester
|
|
esters saturated fatty acids coconuts oils cyclooxygenases cyclooxygenase-2 COX-2 COX2 lipophilic lipid-soluble anaerobic fermentation Saccharomyces cerevisiae nuts dodecanoic PGHS2 PGHS-2 |
1.619921731123
|
| 13353 |
Lignoceric Acid
|
|
557-59-5 |
≥98%
|
|
|
2009-08-04
|
3.057867471523
|
lignoceric-acid
|
FL 88
|
fatty acids brains development cerebrosides sphingomyelin myelin galactoplipids peroxisome Zellweger cerebro-hepato-renal cerebrohepatorenal syndromes X chromosomes X-chromosomes chromosome-linked linked adrenoleukodystrophy lignin FL88 L 88 FL-88 L-88 |
3.057867471523
|
| 90160 |
Linoelaidic Acid
|
|
506-21-8 |
>98%
|
|
|
|
8.549337016575
|
linoelaidic-acid
|
|
trans-fatty acids PUFA octadecadienoic linolelaidic |
8.549337016575
|
| 90150 |
Linoleic Acid
|
|
60-33-3 |
>98%
|
|
|
|
12.073988259668
|
linoleic-acid
|
Telfairic Acid
|
fatty acids PUFA |
12.073988259668
|
| 10010623 |
Linoleic Acid-biotin
|
|
- |
>95%
|
|
|
2008-01-30
|
2.865432780847
|
linoleic-acid-biotin
|
|
fatty acids PUFA polyunsaturated biotinylated affinity probes binding proteins esterified membranes phospholipids regulated pathways receptor-stimulated release metabolisms re-uptake signalling signaling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated biotinamides |
2.865432780847
|
| 390150 |
Linoleic Acid-d4
Exclusive
|
|
79050-23-0 |
≥99% deuterated forms (d1-d4)
|
|
✓ |
|
9.927914364641
|
linoleic-acid-d4
|
|
standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids |
9.927914364641
|
| 10008198 |
Linoleic Acid ethyl ester
|
|
544-35-4 |
>98%
|
|
|
2006-04-25
|
4.563919198895
|
linoleic-acid-ethyl-ester
|
Ethyl Linoleate; Telfairic Acid ethyl ester
|
fatty acids PUFAs polyunsaturated diets wounds healing growth retardation dermatitis 15-LO lipoxygenases plants animals 9-HODE 13-HODE esters lipids lipid-soluble 9Z,12Z-octadecadienoic linolates |
4.563919198895
|
| 90150.1 |
Linoleic Acid (peroxide free)
|
|
60-33-3 |
≥98%
|
|
|
|
4.600883977900
|
linoleic-acid-peroxide-free
|
Telfairic Acid
|
polyunsaturated fatty acids PUFAs |
4.600883977900
|
| 10006834 |
Linoleic Acid Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
2.805607734806
|
linoleic-acid-quant-pak
|
|
Quant-PAKs PUFA standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids packs |
2.805607734806
|
| 10008199 |
Linolenic Acid ethyl ester
|
|
1191-41-9 |
≥98%
|
|
|
2006-05-30
|
5.392430939227
|
linolenic-acid-ethyl-ester
|
Ethyl α-Linolenate; LAEE
|
a-linolenic .alpha.-linolenic alpha-linolenic acids ALA fatty leafy green vegetables cardiovascular disease blood pressure serum cholesterol platelet aggregation esters lipophilic exogenous ethanol-induced metabolite hepatic fibrogenesis intracellular signaling stellate cells HSC cyclin E expression CDK2 activity ERK JNK PUFA omega-3 w-3 .omega.-3 |
5.392430939227
|
| 90155 |
Linoleoyl Ethanolamide
|
|
68171-52-8 |
>98%
|
|
|
|
4.542530386740
|
linoleoyl-ethanolamide
|
|
cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl cbs synthetic |
4.542530386740
|
| 9000553 |
Linoleoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2010-01-13
|
2.351657458564
|
linoleoyl-ethanolamide-d4
|
|
cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic |
2.351657458564
|
| 101730 |
MCAD Polyclonal Antibody
|
|
- |
|
|
|
|
10.273922651933
|
mcad-polyclonal-antibody
|
Medium-chain Fatty Acyl-CoA Dehydrogenase
|
antisera dehydrogenases peroxisome proliferator-activated receptors response element nuclear reactors PPARalpha PPAR.alpha. PPRE human beta-oxidation b-oxidation .beta.-oxidation western blots blotting antibody antibodies WB immunoblotting |
10.273922651933
|
| 90290 |
MEDICA 16
|
|
87272-20-6 |
>98%
|
|
|
|
12.588950276242
|
medica-16
|
|
hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis |
12.588950276242
|
| 10007812 |
Monoacylglycerol Lipase (human recombinant)
|
|
- |
>95%
|
|
|
2008-04-01
|
58.963167587477
|
monoacylglycerol-lipase-human-recombinant
|
MAGL; MGL
|
neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant active |
58.963167587477
|
| 10009566 |
Monoacylglycerol Lipase Western Ready Control
|
|
- |
Whole cell lysate
|
|
|
2007-01-31
|
10.286866614049
|
monoacylglycerol-lipase-western-ready-control
|
MGL; MAGL
|
hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry |
10.286866614049
|
| 63150 |
Myriocin
|
|
35891-70-4 |
>98%
|
|
|
2007-05-03
|
56.576548719507
|
myriocin
|
Thermozymocidin; ISP-1
|
serine palmitoyltransferase inhibitors sphingolipids antibiotic immunosuppressants inhibition inhibited atherosclerosis |
56.576548719507
|
| 13351 |
Myristic Acid
|
|
544-63-8 |
≥98%
|
|
|
2009-08-11
|
1.945130846008
|
myristic-acid
|
NSC 5028
|
fatty acids N-myristoylation 45184-05-2 14-carbon saturated 14:0 |
1.945130846008
|
| 13267 |
Myristic Acid Alkyne
|
|
82909-47-5 |
≥98%
|
|
|
2010-04-05
|
10.885266543891
|
myristic-acid-alkyne
|
Click Tag™ Myristic Acid; 13-alkyne Myristic Acid
|
N-myristoylation alkynes click chemistry bioconjugations click-tag clicktag omega-terminal ω-terminal click it clickit azide-alkyne reactions lipids Tetradecanoic Acids Tetradecanoic Acid Tetradecanoates Myristic Acids Myristic Acid Myristates Myristate |
10.885266543891
|
| 10008197 |
Myristic Acid ethyl ester
|
|
124-06-1 |
>98%
|
|
|
2006-05-30
|
1.673110922226
|
myristic-acid-ethyl-ester
|
Ethyl Myristate; Ethyl Tetradecanoate; NSC 8917
|
esters fatty acids cholesterol saturated animal vegetable fats LDL low density lipoproteins hypercholesterolemic hydrophobic ethanol consumption hair alcohol |
1.673110922226
|
| 10008581 |
Myristoleic Acid methyl ester
|
|
56219-06-8 |
>98%
|
|
|
2007-04-17
|
0.314917127071
|
myristoleic-acid-methyl-ester
|
|
cytotoxic Serenoa S. repens apoptosis necrosis prostate cancers cheese whey fatty acids Candida C. albicans MIC minimal inhibitory concentration in vivo esters hydrophobic |
0.314917127071
|
| 10005537 |
N-Arachidonoyl Taurine
Exclusive
|
|
- |
>98%
|
|
✓ |
2004-11-18
|
7.087296764009
|
n-arachidonoyl-taurine
|
|
bovine brain NADA dopamine ARA-S ARAS N-arachidonoyl-L-serine lipidomics mass spectrometry MS rats N-fatty acyl amides amino acids neurochemistry neuroscience TRPV1 TRPV4 FAAH, cbs, cannabinoids, synthetic |
7.087296764009
|
| 10007288 |
N-Docosanoyl Taurine
|
|
- |
≥98%
|
|
|
2005-12-29
|
0.491139502762
|
n-docosanoyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.491139502762
|
| 10007286 |
N-Lignoceroyl Taurine
|
|
807370-75-8 |
>98%
|
|
|
2005-12-21
|
0.529526440410
|
n-lignoceroyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.529526440410
|
| 10007287 |
N-Nervonoyl Taurine
|
|
- |
>98%
|
|
|
2005-12-29
|
0.529526440410
|
n-nervonoyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.529526440410
|
| 10005611 |
N-Palmitoyl Taurine
|
|
83982-06-3 |
>98%
|
|
|
2005-02-16
|
6.738441199684
|
n-palmitoyl-taurine
|
|
endocannabinoids fatty amides oleamides bovine brain lipidomics rat amino-acyl neurochemistry, cannabinoids cbs synthetic |
6.738441199684
|
| 10005610 |
N-Stearoyl Taurine
|
|
63155-80-6 |
>98%
|
|
|
2005-02-09
|
6.968275453828
|
n-stearoyl-taurine
|
|
endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
6.968275453828
|
| 90510 |
O-11
|
|
119290-12-9 |
>98%
|
|
|
2004-07-06
|
37.960819521178
|
o-11
|
11-Oxatetradecanoic Acid
|
myristic acids Trypanosoma brucei parasites protozoans African sleeping sickness Trypanosine inhibitors trypansomes 10-propoxydecanoic variant surface glycoproteins toxic myristate vsg |
37.960819521178
|
| 90260 |
Oleic Acid
|
|
112-80-1 |
>98%
|
|
|
|
7.873449969306
|
oleic-acid
|
|
fatty acids monounsaturated 9Z-octadecenoic |
7.873449969306
|
| 10010624 |
Oleic Acid-biotin
|
|
- |
>95%
|
|
|
2008-01-30
|
2.809926335175
|
oleic-acid-biotin
|
|
fatty acids PUFA polyunsaturated biotinylated affinity probes binding proteins esterified membranes phospholipids regulated pathways receptor-stimulated release metabolisms re-uptake signalling signaling inflammation detection detected complexes elucidations transports FABPs biotins biontinamides |
2.809926335175
|
| 9000432 |
Oleic Acid-d17
|
|
- |
≥99% deuterated forms (d1-d17)
|
|
|
2010-08-30
|
3.727113259668
|
oleic-acid-d17
|
|
deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids monounsaturated 9Z-octadecenoic Acid cis-9-Octadecenoic
Oleic Acids 12-hydroxy
Oleic Acids, 12 hydroxy
cis-9-Octadecenoic Acid
cis 9 Octadecenoic Acid
Acids, 12-hydroxy Oleic
12-hydroxy Oleic Acids
Acid 9-Octadecenoic
Acids Octadecenoic
9-Octadecenoic Acid
9 Octadecenoic Acid
Octadecenoic Acids
Acids Ricinoleic
Ricinoleic Acids Acids Oleic Oleic Acids Acid Oleic Oleic Acid Oleate |
3.727113259668
|
| 10008201 |
Oleic Acid ethyl ester
|
|
111-62-6 |
>98%
|
|
|
2006-04-25
|
1.936084254143
|
oleic-acid-ethyl-ester
|
Ethyl Oleate
|
monounsaturated fatty acids lipid-soluble membrane phospholipids esters inhibits platelets aggregation fMLF neutrophils degranulation calcium MUFAs 9Z-octadecenoic 9(Z)-octadecenoic |
1.936084254143
|
| 90265 |
Oleoyl Ethanolamide
|
|
111-58-0 |
≥98%
|
|
|
|
19.863959484346
|
oleoyl-ethanolamide
|
Oleic Acid Ethanolamide; OEA
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
19.863959484346
|
| 10007823 |
Oleoyl Ethanolamide-d2
|
|
- |
≥99% deuterated forms (d1-d2)
|
|
|
2006-03-06
|
17.913535911602
|
oleoyl-ethanolamide-d2
|
OEA-d2; Oleic Acid Ethanolamide-d2
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
17.913535911602
|
| 9000552 |
Oleoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1- d4)
|
|
✓ |
2010-01-12
|
10.248737174428
|
oleoyl-ethanolamide-d4
|
Oleic Acid Ethanolamide-d4; OEA-d4
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic |
10.248737174428
|
| 10006529 |
Oleyl Anilide
|
|
5429-85-6 |
≥95%
|
|
|
2005-05-18
|
15.569043380397
|
oleyl-anilide
|
OA; Oleic Acid Anilide
|
HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits glycerides dioleoyl phenylamino propane 1,2-diols eosinophilia excessive T cell activation acute pulmonary inflammatory reactions TOS toxic oil syndrome aniline-denatured cooking oils interleukins atherosclerosis |
15.569043380397
|
| 10008642 |
oxy-Arachidonoyl Ethanolamide
|
|
- |
>98%
|
|
|
2007-09-06
|
13.338195211786
|
oxy-arachidonoyl-ethanolamide
|
oxy-Anandamide; oxy-AEA
|
oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors cannabinoids inhibitors |
13.338195211786
|
| 10010279 |
Palmitate (calcium salt)
|
|
542-42-7 |
>98%
|
|
|
2008-06-30
|
4.404861878453
|
palmitate-calcium-salt
|
Calcium palmitate
|
fatty acids plasma lipoproteins plamitates Ca acetyl coenzyme A palmitic |
4.404861878453
|
| 10006627 |
Palmitic Acid
|
|
57-10-3 |
>98%
|
|
|
2005-04-20
|
12.955420414705
|
palmitic-acid
|
|
saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules |
12.955420414705
|
| 13266 |
Palmitic Acid Alkyne
New
|
|
99208-90-9 |
≥95%
|
|
|
2012-03-12
|
37.354616399193
|
palmitic-acid-alkyne
|
Click Tag™ Palmitic Acid Alkyne
|
click chemistry S-palmitoylation click-tag palmitic acids acylation post-translational modifications palmitate proteins |
37.354616399193
|
| 10008202 |
Palmitic Acid ethyl ester
|
|
628-97-7 |
>98%
|
|
|
2006-05-05
|
4.249295669830
|
palmitic-acid-ethyl-ester
|
Ethyl palmitate; Ethyl hexadecanoate
|
acids saturated fatty diets dietary plasma lipoproteins cytosolic calcium Ca2+ pancreatic acinar cells ethanol COX-2 cyclooxygenases COX2 cyclooxygenase-2 PGHS-2 PGHS2 expression alcoholism alcoholic esters consumption lipophilic lipid-soluble |
4.249295669830
|
| 10007358 |
Palmitic Acid methyl ester
|
|
112-39-0 |
>99%
|
|
|
2006-02-17
|
17.079586883568
|
palmitic-acid-methyl-ester
|
MP; Methyl Palmitate
|
esters saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules |
17.079586883568
|
| 10009871 |
Palmitoleic Acid
|
|
373-49-9 |
≥99%
|
|
|
2008-08-25
|
12.430386740331
|
palmitoleic-acid
|
Palmitoleate; cis-Palmitoleic Acid; 9-cis-Hexadecenoic Acid; n-7 Palmitoleate
|
monounsaturated fatty acids LDL HDL cholesterol diet |
12.430386740331
|
| 9000431 |
Palmitoleic Acid-d14
Exclusive
|
|
- |
≥99% deuterated forms (d1-d14)
|
|
✓ |
2009-12-04
|
10.224696132597
|
palmitoleic-acid-d14
|
|
deuteriums GC/MS internal isotopes standards LC/MS mass spectrometry fatty acids deuterateds GC-MS LC-MS MS |
10.224696132597
|
| 10008204 |
Palmitoleic Acid ethyl ester
|
|
56219-10-4 |
>95%
|
|
|
2006-05-15
|
8.967298956415
|
palmitoleic-acid-ethyl-ester
|
Ethyl Palmitoleate
|
unsaturated fatty acids esters liver glycerides adipose tissues macadamia oils sea buckthorn lipophilic cytosolic calcium Ca2+ pancreas pancreatic acinar cells ethanol death biomarker fetal fetus alcohol |
8.967298956415
|
| 90350 |
Palmitoyl Ethanolamide
|
|
544-31-0 |
≥98%
|
|
|
|
13.010110497237
|
palmitoyl-ethanolamide
|
Palmidrol; PEA
|
endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
13.010110497237
|
| 10007824 |
Palmitoyl Ethanolamide-d4
Exclusive
|
|
1159908-45-8 |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2006-03-06
|
12.649668508287
|
palmitoyl-ethanolamide-d4
|
Palmidrol-d4; PEA-7,7,8,8-d4
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic |
12.649668508287
|
| 9000551 |
Palmitoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2010-01-20
|
6.165601157590
|
palmitoyl-ethanolamide-d4
|
Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4
|
endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic |
6.165601157590
|
| 9000573 |
Palmitoyl Ethanolamide-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2010-03-04
|
5.393704726826
|
palmitoyl-ethanolamide-d5
|
PEA-15,15,16,16,16-d5; Palmidrol-d5
|
endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic |
5.393704726826
|
| 10006451 |
Pentacosanoic Acid methyl ester
|
|
55373-89-2 |
≥98%
|
|
|
2005-10-03
|
56.582243093922
|
pentacosanoic-acid-methyl-ester
|
Methyl Pentacosanoate
|
fatty acids long chain saturateds esters components plant lipids methyl 25-carbon pentacosanoic standard analysis saturates |
56.582243093922
|
| 71655 |
PHOP
|
|
288862-83-9 |
>98%
|
|
|
2005-02-02
|
8.605465666929
|
phop
|
Phenyl hexanoyl oxazolopyridine; CAY10402
|
FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience cbs synthetic |
8.605465666929
|
| 90360 |
Phytanic Acid
|
|
14721-66-5 |
>96%
|
|
|
|
9.413232044199
|
phytanic-acid
|
|
Refsum's disease peroxisome fatty acids |
9.413232044199
|
| 10011499 |
phytanoyl-Coenzyme A (triethylammonium salt)
Exclusive
|
|
- |
≥95%
|
|
✓ |
2008-10-22
|
5.335607734806
|
phytanoyl-coenzyme-a-triethylammonium-salt
|
Phytanic Acid Coenzyme A Ester (triethylammonium salt); phytanoyl-CoA (triethylammonium salt)
|
phytanic acids a-oxidation alpha-oxidation .alpha.-oxidation metabolism fatty peroxisomes Refsums disease Refsum's α-oxidation |
5.335607734806
|
| 10012556 |
Phytomonic Acid
|
|
503-06-0 |
≥98%
|
|
|
2008-09-04
|
10.774696132597
|
phytomonic-acid
|
Lactobacillic Acid
|
saturated fatty acids lactobacillus arabinosus cyclopropane ring cells membranes |
10.774696132597
|
| 10008654 |
Pinolenic Acid
Exclusive
|
|
16833-54-8 |
>98%
|
|
✓ |
2006-09-07
|
28.380874769798
|
pinolenic-acid
|
|
fatty acids polyunsaturated PUFAs CCK GLP-1 ApoA-I ApoA-1 ApoA1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells |
28.380874769798
|
| 10008658 |
Pinolenic Acid ethyl ester
|
|
493015-74-0 |
>98%
|
|
|
2006-09-15
|
2.721795580111
|
pinolenic-acid-ethyl-ester
|
|
fatty acids polyunsaturated PUFAs CCK GLP-1 ApoAI ApoA-I ApoA1 ApoA-1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells lipophilic |
2.721795580111
|
| 10008656 |
Pinolenic Acid methyl ester
|
|
38406-57-4 |
>98%
|
|
|
2007-01-16
|
3.797900552486
|
pinolenic-acid-methyl-ester
|
|
fatty acids polyunsaturated PUFAs CCK GLP-1 ApoAI ApoA-I ApoA1 ApoA-1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells lipophilic esters |
3.797900552486
|
| 10006697 |
Prostaglandin D2-biotin
|
|
- |
>95%
|
|
|
2005-08-03
|
34.030055248618
|
prostaglandin-d2-biotin
|
PGD2-biotin
|
PgD2 biotinylated prostaglandins biotins biotinamide affinity probes ligand receptors PGs |
34.030055248618
|
| 10006987 |
Prostaglandin E2-biotin
|
|
- |
>95%
|
|
|
2005-07-26
|
35.972891344382
|
prostaglandin-e2-biotin
|
PGE2-biotin
|
prostaglandins biotinimides eicosanoids COX-1 COX-2 cyclooxygenases reproductive tissues contracts bronchial smooth muscles regulates fertility implantation FP receptors GPCR affinity probes detected detection interaction biotins ligands transmembrane receptors nucleic acids proteins binding partners tool elucidations mechanisms biotins biotinylated |
35.972891344382
|
| 10006988 |
Prostaglandin F2α-biotin
|
|
- |
>96%
|
|
|
2005-07-26
|
12.379591160220
|
prostaglandin-f2-biotin
|
PGF2α-biotin
|
prostaglandins biotinimides eicosanoids COX-1 COX-2 cyclooxygenases reproductive tissues contracts bronchial smooth muscles regulates fertility implantation FP receptors GPCR affinity probes detected detection interaction biotins ligands transmembrane receptors nucleic acids proteins binding partners tool elucidations mechanisms biotins biotinylated |
12.379591160220
|
| 10006800 |
(R)-Bromoenol lactone
Exclusive
|
|
478288-90-3 |
≥98%
|
|
✓ |
2005-05-31
|
12.755395948434
|
-r-bromoenol-lactone
|
(R)-BEL
|
selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based human recombinants |
12.755395948434
|
| 10534 |
(R)-Bromoenol lactone-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2010-06-17
|
7.613259668508
|
-r-bromoenol-lactone-d7
|
(R)-BEL-d7
|
selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based human recombinants deuterium deuterateds GC/MS LC/MS LC-MS GC-MS mass spectrometry MS signalling standards |
7.613259668508
|
| 10012554 |
Resolvin D1
Exclusive
|
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
256.332392917195
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 |
256.332392917195
|
| 10009729 |
Ricinoleic Acid methyl ester
|
|
141-24-2 |
>98%
|
|
|
2007-05-21
|
0.154696132597
|
ricinoleic-acid-methyl-ester
|
NSC 1254
|
caster oils triglycerides 12-hydroxy fatty acids beans conjugated linoleic acid food humands laxatives synthesis |
0.154696132597
|
| 90353 |
R-Palmitoyl-(1-methyl) Ethanolamide
|
|
142128-47-0 |
>98%
|
|
|
|
5.322567435814
|
r-palmitoyl-1-methyl-ethanolamide
|
R-1 PMA
|
PEA AEA ethanolamides R-1-PMA cannabinoids analogs (R)-methyl ethanolamines inhibitors inhibits CB2 receptors neurochemistry neuroscience |
5.322567435814
|
| 90357 |
R-Palmitoyl-(2-methyl) Ethanolamide
|
|
179951-56-5 |
>98%
|
|
|
|
5.091187845303
|
r-palmitoyl-2-methyl-ethanolamide
|
RP-2ME
|
PEA cannabinoids analogs anandamides methanandamides CB2 receptors ethanolamides inhibits inhibitors (R)-N-(2-hydroxypropyl)-hexadecanamide FAAH fatty acids hydrolases agonists neurochemistry neuroscience ethanolamines |
5.091187845303
|
| 10006801 |
(S)-Bromoenol lactone
|
|
478288-94-7 |
≥98%
|
|
|
2005-05-31
|
12.718747697974
|
-s-bromoenol-lactone
|
(S)-BEL
|
selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based vasopression-induced rat aortic smooth muscle A10 |
12.718747697974
|
| 10535 |
(S)-Bromoenol lactone-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2010-06-17
|
8.306298342541
|
-s-bromoenol-lactone-d7
|
(S)-BEL-d7
|
selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based vasopression-induced rat aortic smooth muscle A10 deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards |
8.306298342541
|
| 70310 |
Sesamin
|
|
607-80-7 |
≥95%
|
|
|
|
28.455469613259
|
sesamin
|
|
.DELTA.5-desaturases inhibitors inhibits DELTA5-desaturases D5-desaturases fatty acids |
28.455469613259
|
| 10011298 |
Stearic Acid
|
|
57-11-4 |
≥98%
|
|
|
2008-10-10
|
4.128574676579
|
stearic-acid
|
|
saturated fatty acids trans LDLs HDLs liporotein cholesterols dietary fats atherosclerosis |
4.128574676579
|
| 10008196 |
Stearic Acid ethyl ester
|
|
111-61-5 |
>98%
|
|
|
2006-05-30
|
1.920913727156
|
stearic-acid-ethyl-ester
|
Ethyl Stearate; Ethyl Octadecanoate; NSC 8919
|
esters saturated acids animal vegetable fats lipid soluble ethanol metabolites cells cycle apoptosis HepG2 excessive alcohol hair |
1.920913727156
|
| 90320 |
Stearidonic Acid
|
|
20290-75-9 |
≥98%
|
|
|
|
90.749429097606
|
stearidonic-acid
|
Moroctic Acid
|
fatty acids polyunsaturated PUFAs omega-3 black currant seeds oil .omega.-3 w-3 6Z,9Z,12Z,15Z-octadecatetraenoic |
90.749429097606
|
| 10006856 |
Stearidonic Acid ethyl ester
|
|
119798-44-6 |
>98%
|
|
|
2005-07-19
|
127.197458563535
|
stearidonic-acid-ethyl-ester
|
Moroctic Acid ethyl ester; Ethyl Stearidonate
|
fatty acids polyunsaturated PUFAs omega-3 black currant seeds oil .omega.-3 w-3 6Z,9Z,12Z,15Z-octadecatetraenoic esters nutraceuticals polyunsaturateds |
127.197458563535
|
| 10005000 |
Stearidonic Acid methyl ester
|
|
- |
>98%
|
|
|
2004-08-12
|
145.806712707182
|
stearidonic-acid-methyl-ester
|
Moroctic Acid methyl ester
|
fatty acids polyunsaturated PUFAs omega-3 black currant seeds oil .omega.-3 w-3 6Z,9Z,12Z,15Z-octadecatetraenoic esters nutraceuticals polyunsaturateds |
145.806712707182
|
| 9000327 |
Stearidonoyl Glycine
|
|
- |
≥98%
|
|
|
2008-12-02
|
0.664493554327
|
stearidonoyl-glycine
|
|
polyunsaturated fatty acids PUFAs stearidonic eicosapentaenoic EPA docosahexaenoic DHA fish oils ALA ω-3 α-linolenic |
0.664493554327
|
| 90245 |
Stearoyl Ethanolamide
|
|
111-57-9 |
>98%
|
|
|
|
13.817389502762
|
stearoyl-ethanolamide
|
Stearic Acid Ethanolamide; Ceramid
|
anandamides N-acyl ethanolamines PLD fatty acids neurochemistry neuroscience ethanolamides |
13.817389502762
|
| 10539 |
Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid
|
|
105528-06-1 |
≥95%
|
|
|
2011-06-06
|
19.725239410681
|
tetratriaconta-16-z-19-z-22-z-25-z-28-z-31-z-hexaenoic-acid
|
|
very long chain fatty acids VLCPUFAs ceramides sphingomyelin retinas sperm brains proteins kinases C polyunsaturated |
19.725239410681
|
| 10006610 |
Thromboxane B1
|
|
64626-32-0 |
>98%
|
|
|
2005-09-13
|
25.741850828729
|
thromboxane-b1
|
|
thromboxanes TXB1 DGLA dihomo-.gamma.-linolenic acids dihomo-g-linolenic metabolites cyclooxygenases COX-1 TXA synthases 20-carbon fatty metabolized prostaglandins COX-2 metabolism human platelets 1-series 12-lipoxygenases 12-LO specific biomarkers ethanol abuses |
25.741850828729
|
| 10005263 |
TOFA
|
|
54857-86-2 |
≥98%
|
|
|
2004-07-28
|
23.026243093922
|
tofa
|
RMI 14514; 5-(Tetradecyloxy)-2-furoic Acid
|
inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology |
23.026243093922
|
| 10008321 |
trans-Δ2-11-methyl-Dodecenoic Acid
|
|
677354-24-4 |
≥98%
|
|
|
2006-04-20
|
24.727071823204
|
trans-2-11-methyl-dodecenoic-acid
|
|
microbial extracellular signaling molecules prokaryotes eukaryotes cells diffusible factors DSF fungal fungus communication systems bioassays biosensors conformational isomers saturated fatty acids signalling cell-cell trans-.DELTA.2-11-methyl-dodecenoic trans-d2-11-methyl-dodecenoic trans-delta2-11-methyl-dodecenoic cis-d2-11-methyl-dodecenoic cis-delta2-11-methyl-dodecenoic bacterial pathogens microbacterium C. albicans |
24.727071823204
|
| 88820 |
Traumatic Acid
|
|
6402-36-4 |
>98%
|
|
|
|
33.676574585635
|
traumatic-acid
|
trans-2-Dodecenedioic Acid
|
acids plants growth regulators hydroperoxide lyase wound healing fatty acids |
33.676574585635
|
| 10010303 |
Triglyceride Colorimetric Assay Kit
|
|
- |
|
|
|
2007-10-31
|
362.235166605279
|
triglyceride-colorimetric-assay-kit
|
|
assays kits triglycerides enzymes enzymatic hydrolysis water-insoluble lipids three fatty acids esterified glycerols blood serums lipoproteins chylomicrons very low density VLDLs dietary fats metabolisms energy diagnosis primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstruction endocrine colorimetric fluorometric plasmas coupled reaction systems |
362.235166605279
|
| 10006731 |
VDM11
|
|
313998-81-1 |
>98%
|
|
|
2005-07-13
|
9.313609576427
|
vdm11
|
|
analogs arachidonoyls ethanolamides AEA anadamides potentiates activity inhibits inhibition reuptake neurons FAAH fatty amides acyls hydrolases transport CB1 CB2 cannabinoids VR1 vanilloid receptors AM404 glutamergic synaptic transmission hippocampal mechanisms sodium channels neurochemistry neuroscience |
9.313609576427
|
| 90210 |
α-Linolenic Acid
|
|
463-40-1 |
>98%
|
|
|
|
13.907580110497
|
-linolenic-acid
|
ALA
|
fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic |
13.907580110497
|
| 9000433 |
α-Linolenic Acid-d14
|
|
- |
≥99% deuterated forms (d1-d14)
|
|
|
2010-09-13
|
8.445831798649
|
-linolenic-acid-d14
|
ALA-d14
|
fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic |
8.445831798649
|
| 90220 |
γ-Linolenic Acid
|
|
506-26-3 |
>98%
|
|
|
|
9.236546961325
|
-linolenic-acid
|
GLA
|
fatty acids PUFAs gamma-linolenic g-linolenic .omega.-6 omega-6 .gamma.-linolenic polyunsaturated w-6 |
9.236546961325
|
| 9000738 |
γ-Linolenic Acid ethyl ester
|
|
31450-14-3 |
≥98%
|
|
|
2011-05-04
|
4.003370165745
|
-linolenic-acid-ethyl-ester
|
GLA ethyl ester
|
fatty acids GLA inhibitors antagonists PUFAs gamma-linolenic g-linolenic .omega.-6 omega-6 .gamma.-linolenic polyunsaturated w-6 inhibition inhibited |
4.003370165745
|
| 10006579 |
γ-Linolenic Acid methyl ester
|
|
16326-32-2 |
>98%
|
|
|
2005-03-04
|
4.030134175216
|
-linolenic-acid-methyl-ester
|
γ-Linolenic Acid methyl ester; Methyl GLA; Methyl γ-Linolenate
|
fatty acids PUFAs gamma-linolenic g-linolenic .omega.-6 omega-6 .gamma.-linolenic polyunsaturated defiency diets bronchioconstriction |
4.030134175216
|
| 10007602 |
Δ2-cis Eicosenoic Acid
|
|
93772-82-8 |
≥98%
|
|
|
2006-01-04
|
0E-12
|
-2-cis-eicosenoic-acid
|
|
.alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-trans D2 extracted fresh wateer clams medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats |
0E-12
|
| 11133 |
Δ2-cis-Hexadecenoic Acid
Exclusive New
|
|
2825-68-5 |
≥98%
|
|
✓ |
2012-01-18
|
1.280441988950
|
-2-cis-hexadecenoic-acid
|
|
quorum sensing myxobacteria autoinducers mono-unsaturated fatty acids bacteria soil marine freshwater cellular cells membranes autotrophic myxococcus |
1.280441988950
|
| 10007622 |
Δ2-trans Eicosenoic Acid
|
|
- |
≥98%
|
|
|
2006-01-04
|
0E-12
|
-2-trans-eicosenoic-acid
|
|
.alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-cis D2 medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats |
0E-12
|
| 11132 |
Δ2-trans-Hexadecenoic Acid
Exclusive New
|
|
929-79-3 |
≥95%
|
|
✓ |
2012-01-20
|
1.280441988950
|
-2-trans-hexadecenoic-acid
|
|
long-chain fatty acids oxidation palmitic intermediates gastric ulcers ulceration unsaturated tissues inhibits inhibition inhibitors pylorus ligated rats |
1.280441988950
|
| 90011 |
ω-3 Arachidonic Acid
|
|
24880-40-8 |
>98%
|
|
|
|
40.431458563536
|
-3-arachidonic-acid
|
|
polyunsaturated fatty PUFAs omega-3 w-3 omega3 w3 cis 8Z,11Z,14Z,17Z-eicosatetraenoic acids 8,11,14,17-eicosatetraenoic fatty acids arachidonates dietary diets essential fish oils |
40.431458563536
|
| 390011 |
ω-3 Arachidonic Acid-d8
|
|
- |
≥99% deuterated product
|
|
|
|
50.047657458563
|
-3-arachidonic-acid-d8
|
|
w-3-AA-d8 GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterium internal isotopes standards deuterated .omega.-3-AA-d8 omega-3-AA-d8 w-3-arachidonic .omega.-3-arachidonic omega-3-arachidonic fatty acids PUFAs polyunsaturated |
50.047657458563
|
| 10009348 |
ω-3 Arachidonic Acid ethyl ester
|
|
123940-93-2 |
>98%
|
|
|
2007-01-05
|
25.942191528545
|
-3-arachidonic-acid-ethyl-ester
|
|
.omega.-3 w-3 omega-3 fatty acids fish oils polyunsaturateds PUFAs diet omega3 w3 GC exogenous 8Z,11Z,14Z,17Z-eicosatetraenoic 8,11,14,17-eicosatetraenoic arachidonoates essential lipid-soluble esters FAME heart diseases thrombosis hypertension inflammatory autoimmune arachidonoyl-CoA synthetases calf brains lipophilic |
25.942191528545
|
| 10006454 |
ω-3 Arachidonic Acid methyl ester
|
|
132712-70-0 |
>98%
|
|
|
2005-06-29
|
21.560128913443
|
-3-arachidonic-acid-methyl-ester
|
|
w-3 omega-3 fatty acids fish oils polyunsaturateds PUFAs diet omega3 w3 GC exogenous 8Z,11Z,14Z,17Z-eicosatetraenoic 8,11,14,17-eicosatetraenoic arachidonoates essential lipid-soluble esters FAME |
21.560128913443
|
| 10006833 |
ω-3 Arachidonic Acid Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
6.199585635359
|
-3-arachidonic-acid-quant-pak
|
|
Quant-PAKs 8,11,14,17-eicosatetraenoic fatty acids w-3-AA-d8 GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterium internal isotopes standards deuterated .omega.-3-AA-d8 omega-3-AA-d8 w-3-arachidonic .omega.-3-arachidonic omega-3-arachidonic fatty acids PUFAs polyunsaturated packs |
6.199585635359
|